PFG Investments
ABOS icon

PFG Investments’s Acumen Pharmaceuticals ABOS Stock Holding History

PFG Investments’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$238K Buy
107,151
+12,901
+14% +$33.4K 0.01% 1079
2026
Q2 		$252K Buy
94,250
+13,400
+17% +$33.1K 0.01% 1057
2026
Q1 		$191K Buy
80,850
+61,850
+326% +$158K 0.01% 1073
2025
Q4 		$40.1K Buy
19,000
+7,500
+65% +$14.9K ﹤0.01% 1124
2025
Q3 		$19.7K Buy
+11,500
New +$15.9K ﹤0.01% 1105

Other funds holding ABOS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Catalyst Financial Partners
Catalyst Financial Partners Boston, Massachusetts $1.07B AUM 26.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

PFG Investments's ABOS Position: Q3 2026 in Review

PFG Investments increased its Acumen Pharmaceuticals (ABOS) stake by 14% in Q3 2026, buying an estimated $33.4K and bringing the position to 107,151 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #1079.

PFG Investments first reported a position in ABOS in Q3 2025 and has held it in 5 quarters since. The position peaked at $252K in Q2 2026. 50 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.

  • PFG Investments held 107,151 shares of Acumen Pharmaceuticals worth $238K as of Q3 2026.
  • PFG Investments bought 12,901 Acumen Pharmaceuticals shares in Q3 2026, an estimated $33.4K.
  • Acumen Pharmaceuticals made up 0.01% of PFG Investments's portfolio in Q3 2026, its #1079 holding.
  • PFG Investments first reported a position in Acumen Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • PFG Investments's Acumen Pharmaceuticals position peaked at $252K in Q2 2026.
  • 50 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.

Based on PFG Investments's 13F filing for Q3 2026, filed 12 Nov 2026.